A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

NCT06132945 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma
Brain Metastases

Interventions

DRUG: Cabozantinib
DEVICE: Nivolumab
RADIATION: Stereotactic Radiosurgery (SRS)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]